Apex Biotechnology Corp. (TPE:1733)
Taiwan · Delayed Price · Currency is TWD 30.45
-0.10 (-0.33%)
Oct 8, 2026, 1:30 PM CST
Apex Biotechnology Market Cap
Apex Biotechnology has a market cap or net worth of 3.04 billion as of October 8, 2026. It is the 25,759th most valuable company in the world and the 1,395th biggest in Taiwan. Its market cap has decreased by 14.35% in one year.
Market Cap
3.04B
Enterprise Value
2.34B
Revenue
1.87B
Global Rank
Country Rank
#1,395 Taiwan
PE Ratio
16.11
ChartMarket Cap Chart
Since September 7, 2001, Apex Biotechnology's market cap has increased from 1.43B to 3.04B, an increase of 113.58%. That is a compound annual growth rate of 3.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 3.04B | - |
| Dec 31, 2025 | 3.04B | 1.16% |
| Dec 31, 2024 | 3.01B | -25.31% |
| Dec 29, 2023 | 4.03B | 57.73% |
| Dec 30, 2022 | 2.55B | -1.73% |
| Dec 30, 2021 | 2.60B | 10.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Delta Asia International | 5.76B |
| Hi-Clearance | 5.68B |
| WeLeader Biomedical | 3.32B |
| Bonraybio | 2.83B |
| Applied BioCode | 2.75B |
| A Plus Biotechnology | 2.51B |
| Wellell | 2.45B |
| Medimaging Integrated Solution | 2.25B |